Clinical Trial Update: Safety and Immunogenicity of Novel Vaccination Schedules With Malaria Vaccines AdCh63 ME-TRAP and MVA ME-TRAP [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial reports safety and immunogenicity data for novel vaccination schedules using malaria vaccines AdCh63 ME-TRAP and MVA ME-TRAP.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• AdCh63 ME-TRAP (AdCh63 ME-TRAP)
• MVA ME-TRAP (MVA ME-TRAP)

Snippet

Sponsor: University of Oxford | Conditions: Malaria | Phase 1 | Status: COMPLETED